CA2624049C - Herbal composition for inflammatory disorders - Google Patents

Herbal composition for inflammatory disorders Download PDF

Info

Publication number
CA2624049C
CA2624049C CA2624049A CA2624049A CA2624049C CA 2624049 C CA2624049 C CA 2624049C CA 2624049 A CA2624049 A CA 2624049A CA 2624049 A CA2624049 A CA 2624049A CA 2624049 C CA2624049 C CA 2624049C
Authority
CA
Canada
Prior art keywords
extract
compound
inflammatory
sphaeranthus indicus
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2624049A
Other languages
English (en)
French (fr)
Other versions
CA2624049A1 (en
Inventor
Vijay Chauhan
Ashish Suthar
Dhananjay Sapre
Swati Bal-Tembe
Ashok Kumar Gangopadhyay
Asha Kulkarni-Almeida
Sapna Hasit Parikh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piramal Enterprises Ltd
Original Assignee
Piramal Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Enterprises Ltd filed Critical Piramal Enterprises Ltd
Publication of CA2624049A1 publication Critical patent/CA2624049A1/en
Application granted granted Critical
Publication of CA2624049C publication Critical patent/CA2624049C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
CA2624049A 2005-09-30 2006-09-28 Herbal composition for inflammatory disorders Active CA2624049C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1226MU2005 2005-09-30
IN1226/MUM/2005 2005-09-30
US73644305P 2005-11-14 2005-11-14
US60/736,443 2005-11-14
PCT/IB2006/053540 WO2007036900A2 (en) 2005-09-30 2006-09-28 Herbal composition for inflammatory disorders

Publications (2)

Publication Number Publication Date
CA2624049A1 CA2624049A1 (en) 2007-04-05
CA2624049C true CA2624049C (en) 2016-01-12

Family

ID=37900158

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2624049A Active CA2624049C (en) 2005-09-30 2006-09-28 Herbal composition for inflammatory disorders

Country Status (10)

Country Link
US (2) US7635494B2 (esCached)
EP (1) EP1931366B1 (esCached)
JP (1) JP5331962B2 (esCached)
AU (1) AU2006296197B2 (esCached)
CA (1) CA2624049C (esCached)
EA (1) EA014070B1 (esCached)
GE (1) GEP20115332B (esCached)
MA (1) MA29890B1 (esCached)
PL (1) PL1931366T3 (esCached)
WO (1) WO2007036900A2 (esCached)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009016565A1 (en) * 2007-07-27 2009-02-05 Piramal Life Sciences Limited Tricyclic compounds for the treatment of inflammatory disorders
WO2009084032A2 (en) * 2007-12-03 2009-07-09 Vedic Elements Private Limited Stable hydrophobic topical herbal formulation
US10105347B2 (en) 2009-02-02 2018-10-23 Laila Nutraceuticals Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
WO2012014216A1 (en) * 2010-07-28 2012-02-02 Laila Nutraceuticals 7-hydroxyfrullanolide and its analogs for prevention, control and treatment of metabolic disorders
CN102292093B (zh) * 2009-02-02 2015-01-28 莱拉营养食品有限公司 用于代谢综合症控制的选自绒毛戴星草和莽吉柿的混合物
WO2011033524A2 (en) * 2009-08-04 2011-03-24 Laila Nutraceuticals Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases
WO2011083397A1 (en) * 2010-01-05 2011-07-14 Himalaya Global Holdings Limited Herbal composition for skin disorders
CN103108556A (zh) * 2010-09-11 2013-05-15 莱拉营养食品有限公司 绒毛戴星草衍生成分
US8263579B2 (en) * 2011-01-24 2012-09-11 Piramal Healthcare Limited Anti-inflammatory compounds
JP2015535236A (ja) * 2012-10-23 2015-12-10 ピラマル・エンタープライゼズ・リミテッドＰｉｒａｍａｌ Ｅｎｔｅｒｐｒｉｓｅｓ Ｌｉｍｉｔｅｄ ＴＮＦ−α媒介性疾患の予防および処置のための薬草組成物
AU2016281656B2 (en) * 2015-06-23 2019-05-30 Nobilis Therapeutics, Inc. Therapeutic immune modulation using noble gas compositions
MY190273A (en) * 2016-05-21 2022-04-11 Laila Impex Dietary supplements and compositions for enhancing physical performance and energy levels

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646687A (en) * 1994-12-29 1997-07-08 Lucent Technologies Inc. Temporally-pipelined predictive encoder/decoder circuit and method
US6204523B1 (en) * 1998-11-06 2001-03-20 Lumileds Lighting, U.S., Llc High stability optical encapsulation and packaging for light-emitting diodes in the green, blue, and near UV range
US6686676B2 (en) * 2001-04-30 2004-02-03 General Electric Company UV reflectors and UV-based light sources having reduced UV radiation leakage incorporating the same
US6989412B2 (en) * 2001-06-06 2006-01-24 Henkel Corporation Epoxy molding compounds containing phosphor and process for preparing such compositions
US6841647B2 (en) * 2001-11-06 2005-01-11 National Starch And Chemical Investment Holding Corporation Fluid resistant silicone encapsulant
US7160972B2 (en) * 2003-02-19 2007-01-09 Nusil Technology Llc Optically clear high temperature resistant silicone polymers of high refractive index
US7261441B2 (en) * 2004-02-27 2007-08-28 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. LED device and method for directing LED light
WO2006016228A2 (en) * 2004-08-02 2006-02-16 Prashanth Kumar V Cytotoxic peptide alkaloid and pharmaceutical compositions for the treatment of neoplastic diseases
US7229934B2 (en) * 2004-10-18 2007-06-12 International Business Machines Corporation Porous organosilicates with improved mechanical properties

Also Published As

Publication number Publication date
AU2006296197A1 (en) 2007-04-05
MA29890B1 (fr) 2008-10-03
EP1931366A2 (en) 2008-06-18
CA2624049A1 (en) 2007-04-05
AU2006296197B2 (en) 2012-08-09
EA014070B1 (ru) 2010-08-30
AU2006296197A2 (en) 2008-06-05
EA200800850A1 (ru) 2008-10-30
JP2009510051A (ja) 2009-03-12
HK1112418A1 (en) 2008-09-05
PL1931366T3 (pl) 2013-11-29
JP5331962B2 (ja) 2013-10-30
US20090269427A1 (en) 2009-10-29
US7635494B2 (en) 2009-12-22
US20080254157A1 (en) 2008-10-16
EP1931366B1 (en) 2013-05-29
US8206756B2 (en) 2012-06-26
WO2007036900A2 (en) 2007-04-05
GEP20115332B (en) 2011-11-25
WO2007036900A3 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
US7635494B2 (en) Herbal composition for inflammatory disorders
KR101285234B1 (ko) 백미 추출물을 포함하는 관절염 예방 및 치료용 조성물
RU2438692C2 (ru) Растительный экстракт и его терапевтическое применение
KR20170066585A (ko) 골관절염에 대한 상승적인 조성물
US8945633B2 (en) Pharmaceutical composition for preventing and treating inflammatory diseases containing an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, and method for producing the fraction
CN113773409B (zh) 倒心盾翅藤多糖及其用途
EP1414475B1 (en) An herbal composition for the treatment and remedy of bronchial respiratory difficulties
CN101304756B (zh) 用于炎性病症的草药组合物
JP2000503686A (ja) 黄栢皮とオミナエシ植物の混合抽出物を含有するｃ型肝炎治療用製薬組成物
US7862837B2 (en) Herbal composition
US6413553B1 (en) Herbal formulation of a combination of Piper betel and Murrya koenigii extracts for blocking 5 lipoxygenase activity
Aiyalu et al. Formulation and Evaluation of Novel Herbal Aerosol for Arthritis
HK1112418B (en) Herbal composition for inflammatory disorders
KR101132110B1 (ko) 식물 추출물을 포함하는 치주질환용 조성물
MX2008004291A (es) Composicion herbaria para trastornos inflamatorios
Dafar et al. A Review on Phytochemical and Pharmacological Study of Herbal Medicinal Plant: Abrus precatorious
Gopalakrishnan et al. Antihepatotoxic acticity of Coccinia indica
Onwuzuligbo et al. Evaluation of anti-inflammatory activities of ethanolic extract and solvent fractions of Cleistopholis staudtii leaves
Vieira et al. Gastro-protective effects of isobrucein B, a quassinoid isolated from Picrolemma sprucei
WO2023037299A1 (en) Anti-inflammatory compositions comprising ginger and turmeric
Henri et al. Effects of Cola anomala (K. Schum.) water/ethanol pods extract on the inflammation and intestinal secretion in lipopolysaccharide-induced diarrhea.
KR20250104596A (ko) 동맥경화 인자 억제효과를 갖는 항염증 효능 기반 자귀나무 포함 복합조성물
CN103330722A (zh) 一种长白山红蚂蚁提取物的制备方法
KR20160087371A (ko) 정공등복합방 추출물을 포함하는 항산화 및 항염증용 약학적 조성물

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240926

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240926